Background illustration for clinical trials search

Paid Clinical Trials Kent

Discover 1,441 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

for
Breast Neoplasms
Location: Tacoma WA, Saskatoon, Grand Junction CO, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07060807

Phase3, Recruiting

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

for
Patients With Non-Small Cell Lung Cancer
Location: Tacoma WA, Puyallup WA, Gig Harbor WA, Beverly Hills CA,
Sponsor: OSE Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06472245

Phase3, Recruiting

SLV-154 Treatment of Advanced Cancers

for
Advanced Cancer, Advanced Solid Tumor, Metastatic Cancer
Location: Tacoma WA, Seattle WA, Newport Beach CA, St Louis MO,
Sponsor: Solve Therapeutics

Sex: All

Age: 12+

Code: NCT06771219

Phase1, Recruiting

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

for
Gastroesophageal-junction Cancer, Monoclonal Antibody,
Location: Tacoma WA, Olympia WA, Las Vegas NV, Anaheim CA,
Sponsor: Shanghai Henlius Biotech

Sex: All

Age: 18+

Code: NCT06532006

Phase3, Recruiting

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

for
Breast Cancer, Breast Cancer Metastatic,
Location: Tacoma WA, Dallas TX, Fort Wayne IN, Houston TX,
Sponsor: Incyclix Bio

Sex: All

Age: 18+

Code: NCT05735080

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

for
Paroxysmal Atrial Fibrillation
Location: Tacoma WA, Puyallup WA, Ventura CA, Aurora CO,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Sex: All

Age: 18+

Code: NCT06324201

Recruiting

Limited Versus Extended Trophic Feeding (LET-FEED) Trial

for
Sepsis, Length of Stay, Mortality, Neurodevelopmental Delay
Location: Tacoma WA
Sponsor: University of Washington

Sex: All

Age: 0 - 2

Code: NCT06893939

Phase2, Phase3, Recruiting

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

for
Atrial Fibrillation
Location: Tacoma WA, Sacramento CA, Stanford CA,
Sponsor: Johns Hopkins University

Sex: All

Age: 22 - 70+

Code: NCT05836987

Phase3, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Issaquah WA, Seattle WA, Edmonds WA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase3, Recruiting

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Issaquah WA, Seattle WA, Silverdale WA, Edmonds WA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06580314

Phase3, Recruiting

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

for
Breast Cancer
Location: Puyallup WA, Omaha NE, Fort Wayne IN, Houston TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07205822

Phase3, Recruiting

Lay-Delivered Behavioral Activation in Senior Centers

for
Depression
Location: Tacoma WA, Seattle WA, Enumclaw WA, New York NY,
Sponsor: University of Washington

Sex: All

Age: 60+

Code: NCT04621877

Recruiting

Usability, Immediate, and 30 Day Effect of External Neuromodulation With iTEAR100 Generation 2 in Dry Eye Patients

for
Dry Eye
Location: Issaquah WA, Seattle WA
Sponsor: Olympic Ophthalmics, Inc.

Sex: All

Age: 21+

Code: NCT05304637

Recruiting

A Usability Study of iTEAR100 For Combined EyeLid Microblepharoexfoliation and Neurostimulation

for
MicroBlepharoexfoliation, NuLids, iTEAR100, iLIDS100, Blepharitis, Dry Eye Syndrome,
Location: Issaquah WA
Sponsor: Olympic Ophthalmics, Inc.

Sex: All

Age: 18+

Code: NCT06235450

Phase1, Recruiting

A Usability Study of External Neuromodulation With iTEAR100 Generation 2

for
Dry Eye Syndromes
Location: Issaquah WA
Sponsor: Olympic Ophthalmics, Inc.

Sex: All

Age: 18+

Code: NCT05304650

Recruiting

Impella RP Flex with Smart Assist

for
Right Ventricular (RV) Dysfunction
Location: Puyallup WA, Portland OR, Spokane WA, Missoula MT,
Sponsor: Abiomed Inc.

Sex: All

Age: 0+

Code: NCT06637644

Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Tacoma WA, Seattle WA, Olympia WA, Salem OR, Spokane WA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase3, Recruiting

Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL

for
Diffuse Large B-Cell Lymphoma
Location: Tacoma WA, Des Moines IA
Sponsor: AstraZeneca

Sex: All

Age: 65 - 70+

Code: NCT05952024

Phase2, Recruiting

Lysosomal Acid Lipase (LAL) Deficiency Registry

for
Lysosomal Acid Lipase Deficiency,
Location: Tacoma WA, Edmonton, Stanford CA, Phoenix AZ,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 0+

Code: NCT01633489

Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Tacoma WA, Vancouver, Grand Junction CO, Los Angeles CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase3, Recruiting